Dr. Samir J. Azzam, MD

Dr. Azzam practices at AHMC Anaheim Regional Medical Center in Anaheim, California, part of AHMC Healthcare.

Dr. Azzam's NPI, 1891744538, was assigned on May 9, 2006. Dr. Azzam graduated from Damascus University Faculty of Medicine in 1987. Dr. Azzam holds California license A51621.

Dr. Azzam's primary practice is AHMC Anaheim Regional Medical Center, at 1111 W La Palma Avenue, Anaheim, CA 92801 in Orange County. The practice phone is (714) 774-1450.

Dr. Azzam's primary practice is AHMC Anaheim Regional Medical Center in Anaheim, California, part of AHMC Healthcare. Dr. Azzam is also affiliated with Anaheim Global Medical Center. The medical group on file is Family Choice Medical Group. Dmand AI also links Dr. Azzam to 4 more hospitals, 5 skilled nursing facilities, 4 home health agencies, 2 hospices and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azzam practices, 18 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Azzam's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Azzam is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Azzam's licenses on file in 2 states: California and Michigan.

Dmand AI lists acid reflux, acute diabetes, acute respiratory failure, acute sinusitis, acute stomach ulcer, anemia, aneurysm and anxiety among the conditions Dr. Azzam treats.

CMS data shows 4,476 Medicare services from Dr. Azzam across 8 procedure codes in 2024, for 478 Medicare patients. Medicare paid $309,733 for them.

CMS counts 478 Medicare patients who saw Dr. Azzam in 2024. The largest group is 65 to 74, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 74% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Azzam's median patient age at 61, with 53% women.

In 2024, Dr. Azzam wrote 16,796 Medicare Part D claims for 761 patients. 83% of them were for generic drugs. CMS names the drug for 15,832 of them, across 229 drugs with 11 or more claims each, at $1,352,334 in total drug cost. In 2023, CMS named 15,464 claims across 209 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 17 out of 100 for Dr. Azzam for performance year 2024, reported individually. Dr. Azzam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Azzam to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Constipation, Bronchiolitis Obliterans Syndrome and Signs and Symptoms, Digestive. Bausch Health Americas, Inc. sponsors the most, 2.

CMS Open Payments shows 187 general payments to Dr. Azzam from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,513. It also lists 1 research payment totaling $38,500 in 2016.

Dr. Azzam graduated from Damascus University Faculty of Medicine in 1987.

Dr. Azzam is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.